0,767  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,642  0,001  Alpha-mannosidase inhibitor
0,622  0,001  Mannosidase inhibitor
0,555  0,003  Raf kinase C inhibitor
0,511  0,002  Glucosylceramidase inhibitor
0,484  0,014  Antimitotic
0,508  0,039  GST A substrate
0,475  0,032  5 Hydroxytryptamine release stimulant
0,456  0,025  Cytostatic
0,426  0,002  Gaucher disease treatment
0,426  0,010  Antineoplastic (squamous cell carcinoma)
0,443  0,039  Teratogen
0,411  0,020  DNA synthesis inhibitor
0,393  0,003  Purinergic P2T antagonist
0,405  0,026  Radiosensitizer
0,405  0,038  Radioprotector
0,400  0,040  ICAM1 expression inhibitor
0,384  0,026  Myocardial infarction treatment
0,400  0,042  Embryotoxic
0,395  0,047  Antifungal
0,374  0,036  Interleukin 2 agonist
0,375  0,039  Chemoprotective
0,336  0,008  Antineoplastic antibiotic
0,380  0,056  Immunostimulant
0,353  0,031  Antineoplastic (endocrine cancer)
0,364  0,049  NOS3 expression inhibitor
0,416  0,102  Caspase 9 stimulant
0,393  0,080  Antibacterial
0,338  0,028  GST M1-1 substrate
0,322  0,019  Antineoplastic (carcinoma)
0,364  0,061  Prostate cancer treatment
0,343  0,046  UGT2B4 substrate
0,329  0,032  5 Hydroxytryptamine uptake stimulant
0,306  0,022  Pneumotoxic
0,292  0,010  GABA C receptor agonist
0,292  0,013  Nitric-oxide synthase stimulant
0,321  0,055  Antineoplastic (small cell lung cancer)
0,312  0,047  Antineoplastic (renal cancer)
0,313  0,049  Cytotoxic
0,357  0,096  TNF expression inhibitor
0,271  0,012  UDP-glucose 4-epimerase inhibitor
0,308  0,059  FMO3 substrate
0,250  0,004  Antiprotozoal activity enhancer
0,339  0,097  Antipruritic, allergic
0,282  0,043  Tyrosine 3 hydroxylase inhibitor
0,270  0,038  Peptidyltransferase inhibitor
0,323  0,092  Antileukemic
0,311  0,081  Calcium channel activator
0,310  0,081  FMO1 substrate
0,252  0,025  Tubulin antagonist
0,282  0,058  Interleukin agonist
0,361  0,139  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,265  0,046  Antihypotensive
0,261  0,043  RNA-directed DNA polymerase inhibitor
0,216  0,004  Antiviral (Dengue virus)
0,320  0,110  Antineoplastic (breast cancer)
0,270  0,061  Angiogenesis stimulant
0,295  0,091  Antithrombotic
0,252  0,049  Anesthetic general
0,218  0,016  Antiviral (Poxvirus)
0,208  0,009  Antiviral (Influenza B)
0,226  0,028  UGT2B9 substrate
0,216  0,020  Antineoplastic antimetabolite
0,206  0,012  Antineoplastic alkaloid
0,217  0,028  Uterine stimulant
0,335  0,148  Apoptosis agonist
0,222  0,037  Amylase inhibitor
0,211  0,026  Cell wall synthesis inhibitor
0,210  0,028  Aldose reductase substrate
0,199  0,020  Microtubule formation inhibitor
0,270  0,092  CTGF expression inhibitor
0,250  0,073  Cardiovascular analeptic
0,208  0,030  Antirickettsial
0,246  0,068  Antineoplastic (lymphoma)
0,267  0,093  Respiratory analeptic
0,261  0,088  Antihypoxic
0,205  0,033  UGT2B10 substrate
0,183  0,013  Triose-phosphate isomerase inhibitor
0,219  0,049  Antipruritic, non-allergic
0,178  0,008  Antidote, mercury
0,182  0,012  NADH dehydrogenase inhibitor
0,250  0,083  UGT1A9 substrate
0,186  0,021  Adenylate cyclase stimulant
0,247  0,083  Aldehyde oxidase inhibitor
0,173  0,011  Ca2+-transporting ATPase inhibitor
0,260  0,100  Analeptic
0,188  0,029  CF transmembrane conductance regulator agonist
0,201  0,043  Antiviral (Influenza A)
0,161  0,005  Dopamine transporter inhibitor
0,171  0,015  Phosphofructokinase-1 inhibitor
0,215  0,061  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,192  0,040  Hexokinase inhibitor
0,200  0,051  Antihelmintic (Nematodes)
0,170  0,022  Antineoplastic, alkylator
0,251  0,106  CYP2D6 substrate
0,182  0,039  SULT1A3 substrate
0,234  0,093  Flavin-containing monooxygenase substrate
0,190  0,052  Phospholipase C inhibitor
0,166  0,030  Excitatory amino acid transporter EAAC1 inhibitor
0,146  0,012  Carbamoyl phosphate synthetase inhibitor
0,184  0,049  Arachidonic acid antagonist
0,254  0,122  Cholesterol antagonist
0,258  0,126  Vasodilator, coronary
0,193  0,065  UGT2B7 substrate
0,200  0,072  UGT1A1 substrate
0,153  0,025  Adenylate kinase inhibitor
0,143  0,018  UGT2B11 substrate
0,197  0,074  Abortion inducer
0,228  0,106  Antineoplastic (pancreatic cancer)
0,201  0,079  Psychostimulant
0,244  0,122  AR expression inhibitor
0,174  0,053  Carcinogenic, group 1
0,217  0,096  Antineoplastic (non-small cell lung cancer)
0,247  0,129  Vasodilator, peripheral
0,226  0,111  Cardioprotectant
0,142  0,029  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,289  0,177  5 Hydroxytryptamine release inhibitor
0,126  0,015  Glycine receptor antagonist
0,140  0,029  Creatine kinase inhibitor
0,202  0,092  UGT1A6 substrate
0,115  0,004  Andropause treatment
0,258  0,148  GABA C receptor rho-3 antagonist
0,123  0,014  Alcohol oxidase inhibitor
0,135  0,026  GST T1-1 substrate
0,167  0,059  Interferon gamma antagonist
0,131  0,024  Antibiotic
0,136  0,029  Prolactin inhibitor
0,152  0,045  Antihemorrhagic
0,152  0,045  Alkylator
0,119  0,015  Argininosuccinate synthase inhibitor
0,187  0,083  Antiviral (Influenza)
0,188  0,084  Antiviral (Ebola)
0,192  0,094  Antiparkinsonian, rigidity relieving
0,205  0,107  Antiviral (West Nile virus)
0,181  0,083  UDP-glucuronosyltransferase substrate
0,211  0,114  Antineoplastic (ovarian cancer)
0,209  0,113  Proliferative diseases treatment
0,149  0,054  Cocaine dependence treatment
0,152  0,056  Antifungal (Cryptococcus)
0,134  0,041  GABA C receptor antagonist
0,125  0,033  Electrolyte absorption antagonist
0,100  0,009  SULT2A1 substrate
0,114  0,025  Glutamate dehydrogenase inhibitor
0,195  0,106  NOS2 expression inhibitor
0,101  0,012  Antibiotic Glycopeptide-like
0,128  0,042  GST P1-1 substrate
0,157  0,072  Antimutagenic
0,139  0,055  DNA polymerase I inhibitor
0,232  0,149  CYP3A4 substrate
0,239  0,157  Immunosuppressant
0,150  0,069  UGT2B15 substrate
0,119  0,040  Anabolic
0,198  0,119  Superoxide dismutase inhibitor
0,097  0,018  Antidote, organophosphates
0,085  0,007  Glucose-6-phosphate isomerase inhibitor
0,178  0,102  Cardiodepressant
0,123  0,048  Expectorant
0,127  0,052  Constipation treatment
0,159  0,085  Aldehyde oxidase substrate
0,082  0,009  Anesthetic inhalation
0,093  0,020  MAP kinase kinase 7 inhibitor
0,182  0,109  Cyclic AMP phosphodiesterase inhibitor
0,109  0,037  Antispirochetal
0,175  0,103  VEGF expression inhibitor
0,139  0,068  Antifungal enhancer
0,124  0,053  SULT1A1 substrate
0,088  0,017  Antiviral (Parainfluenza)
0,101  0,031  Histidine decarboxylase inhibitor
0,094  0,025  Glycine receptor agonist
0,225  0,156  Sodium/bile acid cotransporter inhibitor
0,161  0,093  Succinate dehydrogenase inhibitor
0,086  0,018  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,100  0,032  Na+ K+ transporting ATPase inhibitor
0,088  0,022  Biliverdin reductase inhibitor
0,095  0,029  Narcotic antagonist
0,120  0,055  Glutathione S-transferase substrate
0,080  0,016  Sphingosine kinase inhibitor
0,084  0,020  Antimycoplasmal
0,179  0,117  VCAM1 expression inhibitor
0,143  0,081  Peroxidase inhibitor
0,085  0,023  Dopamine uptake inhibitor
0,150  0,089  Antiviral (Hepatitis C)
0,179  0,119  Antihypercholesterolemic
0,086  0,026  Phospholipase D inhibitor
0,109  0,051  GABA C receptor rho-1 antagonist
0,080  0,022  Acyl-CoA dehydrogenase inhibitor
0,127  0,070  Cyclooxygenase 3 inhibitor
0,185  0,129  DNA damaging
0,114  0,058  Ferrochelatase inhibitor
0,112  0,056  UGT2B1 substrate
0,116  0,061  Cystathionine beta-synthase inhibitor
0,158  0,103  Antiviral (Hepatitis)
0,079  0,025  Glutamate (mGluR6) antagonist
0,135  0,082  Acaricide
0,142  0,090  UGT1A3 substrate
0,137  0,086  Heat shock protein 70 antagonist
0,076  0,026  Androgen agonist
0,071  0,021  Sphingosine kinase 2 inhibitor
0,061  0,011  Dopamine D5 agonist
0,141  0,091  Mutagenic
0,103  0,054  Protein kinase C mu inhibitor
0,144  0,097  Muscular dystrophy treatment
0,141  0,094  Melanin inhibitor
0,087  0,042  Interferon agonist
0,169  0,125  Antineoplastic (cervical cancer)
0,074  0,030  Interferon inducer
0,051  0,009  Purinergic P2X agonist
0,045  0,003  1,3-Beta-glucan synthase inhibitor
0,068  0,027  Ornithine carbamoyltransferase inhibitor
0,061  0,020  Adenosine deaminase inhibitor
0,054  0,013  Sphingosine kinase 1 inhibitor
0,130  0,090  Skeletal muscle relaxant
0,061  0,021  Antiviral (Herpesvirus 3, Human)
0,047  0,007  Purinergic P2Y12 antagonist
0,080  0,042  Aminopeptidase I inhibitor
0,072  0,034  MDM2 inhibitor
0,051  0,013  Kainate receptor agonist
0,136  0,098  Neuropathy treatment
0,160  0,123  Neurotrophic factor enhancer
0,049  0,014  Antibiotic Aminoglycoside-like
0,104  0,069  Antihelmintic (Fasciola)
0,215  0,181  Ulceration
0,133  0,099  UGT1A4 substrate
0,131  0,098  Eye irritation, high
0,114  0,081  Antifungal (Pneumocystis)
0,092  0,060  SULT1E1 substrate
0,073  0,041  Selectin antagonist
0,065  0,034  Prolactin release inhibitor
0,087  0,056  Carcinogenic, group 2A
0,050  0,020  Guanylate cyclase inhibitor
0,038  0,008  Purinergic P2Y15 antagonist
0,050  0,021  Growth hormone release inhibitor
0,097  0,067  Chronic obstructive bronchitis treatment
0,128  0,100  Antiviral (Herpes)
0,033  0,006  Vesicular acetylcholine transporter inhibitor
0,039  0,013  Hypoxanthine phosphoribosyltransferase inhibitor
0,050  0,026  Adenylate cyclase 1 inhibitor
0,077  0,053  Nicotinic alpha4beta2 receptor antagonist
0,051  0,027  Microtubule stabilization
0,159  0,135  Platelet antagonist
0,028  0,005  S-adenosyl-L-homocysteine hydrolase inhibitor
0,180  0,157  CYP2C19 substrate
0,137  0,114  Sensitization
0,125  0,102  Genotoxic
0,041  0,018  Fumarate hydratase inhibitor
0,082  0,060  Estrogen-related receptor beta agonist
0,080  0,058  Carbonic anhydrase VI inhibitor
0,130  0,109  Muscle relaxant
0,092  0,071  Phosphodiesterase 6D inhibitor
0,051  0,031  Antimetabolite
0,025  0,005  Antibiotic Anthracycline-like
0,068  0,048  Phenylalanine 4-hydroxylase inhibitor
0,038  0,018  Sodium-dependent vitamin C transporter 2 inhibitor
0,140  0,121  Lipocortins synthesis antagonist
0,092  0,073  Sulfotransferase substrate
0,071  0,053  Glutamate decarboxylase inhibitor
0,023  0,005  Telomerase stimulant
0,043  0,025  Thymidine kinase inhibitor
0,115  0,100  Antiparkinsonian, tremor relieving
0,097  0,082  Mucolytic
0,120  0,105  Chemopreventive
0,081  0,066  Histamine N-methyltransferase inhibitor
0,037  0,022  Ceramide glucosyltransferase inhibitor
0,100  0,086  Carcinogenic, group 3
0,039  0,025  Glutamate (mGluR8) agonist
0,137  0,124  Hepatoprotectant
0,027  0,014  Sodium/glucose cotransporter 1 inhibitor
0,029  0,016  Hedgehog signaling activator
0,021  0,008  Adenosine A3 receptor agonist
0,027  0,015  Vanilloid 2 agonist
0,056  0,045  Lipocortins synthesis agonist
0,027  0,016  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,036  0,025  Arginase inhibitor
0,026  0,016  Sodium/glucose cotransporter inhibitor
0,025  0,015  Adenosine A1 receptor agonist
0,066  0,056  Anticholelithogenic
0,112  0,102  Protein kinase stimulant
0,070  0,060  S-adenosyl-L-methionine decarboxylase inhibitor
0,057  0,048  Adrenaline uptake inhibitor
0,017  0,008  Purinergic P2Y1 agonist
0,095  0,086  DOPA decarboxylase inhibitor
0,099  0,091  Photosensitizer
0,040  0,032  Cholesterol absorption inhibitor
0,016  0,009  Thromboxane A2 agonist
0,054  0,048  Cyclin-dependent kinase 6 inhibitor
0,026  0,019  Sodium/glucose cotransporter 2 inhibitor
0,022  0,016  GRP78 expression inhibitor
0,215  0,209  Alpha-glucosidase inhibitor
0,012  0,007  Purine nucleoside phosphorylase inhibitor
0,091  0,086  Beta glucuronidase inhibitor
0,020  0,015  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,127  0,124  Nitric oxide antagonist
0,010  0,008  Purinergic P2Y2 agonist
0,055  0,052  Purinergic P2X1 antagonist
0,051  0,049  Raf kinase B inhibitor
0,017  0,016  Methylmalonyl-CoA mutase inhibitor
0,103  0,102  Contraceptive female

